Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Emiko INOUE |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Resequencing and association analysis of GAP43 with autism spectrum disorder and schizophrenia in a Japanese population / Reza K. ARTA in Research in Autism Spectrum Disorders, 82 (April 2021)
[article]
Titre : Resequencing and association analysis of GAP43 with autism spectrum disorder and schizophrenia in a Japanese population Type de document : Texte imprimé et/ou numérique Auteurs : Reza K. ARTA, Auteur ; Yuichiro WATANABE, Auteur ; Emiko INOUE, Auteur ; Yoshihiro NAWA, Auteur ; Ryo MORIKAWA, Auteur ; Jun EGAWA, Auteur ; Itaru KUSHIMA, Auteur ; Hirofumi IGETA, Auteur ; Satoshi HOYA, Auteur ; Atsunori SUGIMOTO, Auteur ; Andi J. TANRA, Auteur ; Norio OZAKI, Auteur ; Toshiyuki SOMEYA, Auteur Article en page(s) : 101729 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder GAP43 Japanese Schizophrenia Index. décimale : PER Périodiques Résumé : Background Growth-associated protein 43 (GAP43), a synaptic protein involved in axonal growth and synaptic plasticity, is implicated in the pathophysiology of autism spectrum disorder (ASD) and schizophrenia. To examine the role of rare GAP43 variants in the genetic etiology of ASD and schizophrenia in a Japanese population, we performed resequencing and association analysis. Methods First, we resequenced the GAP43 coding region in 295 ASD patients, 323 schizophrenia patients and 304 controls. Second, we genotyped rs561268447 in 273 ASD patients, 1,150 schizophrenia patients and 1,022 controls. Third, we performed an association analysis of rs561268447 in 568 ASD patients, 1,473 schizophrenia patients and 10,127 controls. Results We identified a rare putatively damaging missense variant (rs561268447) in an ASD patient via resequencing. However, we did not detect the variant in 2,445 individuals via genotyping. The variant was not significantly associated with ASD or schizophrenia in the association analysis. Conclusion This study does not provide evidence for the contribution of rare GAP43 variants to ASD or schizophrenia susceptibility in the Japanese population. En ligne : https://doi.org/10.1016/j.rasd.2021.101729 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443
in Research in Autism Spectrum Disorders > 82 (April 2021) . - 101729[article] Resequencing and association analysis of GAP43 with autism spectrum disorder and schizophrenia in a Japanese population [Texte imprimé et/ou numérique] / Reza K. ARTA, Auteur ; Yuichiro WATANABE, Auteur ; Emiko INOUE, Auteur ; Yoshihiro NAWA, Auteur ; Ryo MORIKAWA, Auteur ; Jun EGAWA, Auteur ; Itaru KUSHIMA, Auteur ; Hirofumi IGETA, Auteur ; Satoshi HOYA, Auteur ; Atsunori SUGIMOTO, Auteur ; Andi J. TANRA, Auteur ; Norio OZAKI, Auteur ; Toshiyuki SOMEYA, Auteur . - 101729.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 82 (April 2021) . - 101729
Mots-clés : Autism spectrum disorder GAP43 Japanese Schizophrenia Index. décimale : PER Périodiques Résumé : Background Growth-associated protein 43 (GAP43), a synaptic protein involved in axonal growth and synaptic plasticity, is implicated in the pathophysiology of autism spectrum disorder (ASD) and schizophrenia. To examine the role of rare GAP43 variants in the genetic etiology of ASD and schizophrenia in a Japanese population, we performed resequencing and association analysis. Methods First, we resequenced the GAP43 coding region in 295 ASD patients, 323 schizophrenia patients and 304 controls. Second, we genotyped rs561268447 in 273 ASD patients, 1,150 schizophrenia patients and 1,022 controls. Third, we performed an association analysis of rs561268447 in 568 ASD patients, 1,473 schizophrenia patients and 10,127 controls. Results We identified a rare putatively damaging missense variant (rs561268447) in an ASD patient via resequencing. However, we did not detect the variant in 2,445 individuals via genotyping. The variant was not significantly associated with ASD or schizophrenia in the association analysis. Conclusion This study does not provide evidence for the contribution of rare GAP43 variants to ASD or schizophrenia susceptibility in the Japanese population. En ligne : https://doi.org/10.1016/j.rasd.2021.101729 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443